Fed. Circ. Questions Medical Training Co.'s $100M Deal Theory
By Ivan Moreno · September 11, 2026, 6:14 PM EDT
A medical training startup urged the Federal Circuit on Friday to revive claims accusing Galderma of a "classic catch-and-kill strategy" to derail what it says could have been a $100 million...
To view the full article, register now.